Quarterly report pursuant to Section 13 or 15(d)

Government Grant - Additional Information (Details)

v3.23.1
Government Grant - Additional Information (Details) - USD ($)
$ in Thousands
 3 Months Ended
Aug. 01, 2021
Mar. 31, 2023
Dec. 31, 2022
Government Grant [Line Items]      
Grant receivable   $ 89 $ 105
NIDA      
Government Grant [Line Items]      
Grant awarded $ 300 2,500  
ORCA-V1 Clinical Study Costs      
Government Grant [Line Items]      
Grant awarded   2,800  
NIDA/NIH      
Government Grant [Line Items]      
Grant awarded   2,500  
Reduction in R&D expense   500  
Grant receivable   100  
Reimbursements received.   $ 1,600